Baskaran D, Spirin P V, Prasolov V S
Mol Biol (Mosk). 2010 May-Jun;44(3):418-30.
Leukemia is a heterogeneous group of malignant blood diseases, it could be characterized by the expansion of immature blast cells. It's still stay unknown the point molecular mechanism of leukemogenesis. It has been previously found that leukemia patients frequently have the mutations in genes responsible for normal proliferation and differentiation of hematopoietic stem cells. At present, scientific groups worldwide engaged in biomedical studies of structural and functional aspects of leukemic oncogenes and their role in human and beast leukemogenesis. In this review we describe the most recent conceptions of molecular properties of oncogenes activation of which may lead to the development of CBF-AML, in case of mutation in core-binding factors AML1 (CBFalpha) or CBFbeta.
白血病是一组异质性的恶性血液疾病,其特征为未成熟原始细胞的扩增。白血病发生的关键分子机制仍不清楚。此前已发现,白血病患者常出现负责造血干细胞正常增殖和分化的基因突变。目前,全球科研团队都在从事白血病致癌基因的结构和功能方面及其在人类和动物白血病发生中作用的生物医学研究。在本综述中,我们描述了致癌基因分子特性的最新概念,其激活可能导致核心结合因子AML1(CBFα)或CBFβ发生突变时出现核心结合因子急性髓系白血病(CBF-AML)。